Counterfeit and Substandard medicine in Laos Report country.

Slides:



Advertisements
Similar presentations
Welcome to Who Wants to be a Millionaire
Advertisements

1 Yell / The Law and Special Education, Second Edition Copyright © 2006 by Pearson Education, Inc. All rights reserved.
Impact Assessment in the policy cycle at the European Commission
Practice Sheet: 21.A. #BUS RIDE-in SCHOOL GO DENTIST- [1]
Accredited Supplier Communications Plan FY09-10 Q1 to Q4 May 2009, v2.0 Home Access Marketing & Stakeholder Engagement Team.
1_Panel Production. 380 pannelli 45 giorni di produzione = 8.4 pannelli/day.
Feichter_DPG-SYKL03_Bild-01. Feichter_DPG-SYKL03_Bild-02.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. *See PowerPoint Lecture Outline for a complete, ready-made.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 116.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Appendix 01.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 107.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 40.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 28.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 44.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 38.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 58.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 112.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 75.
Chapter 1 Image Slides Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
الرابطة الدولية لمكافحة المواد الطبيّة المزورة a WHO initiative to combat counterfeit medical products Dr V. Reggi - World Health Organization.
1 October 16, Secretary of the Department of Administration, Chair Director of the Public Employees Insurance Agency Secretary of the Department.
Performance of Hedges & Long Futures Positions in CBOT Corn Goodland, Kansas March 2, 2009 Daniel OBrien, Extension Ag Economist K-State Research and Extension.
Combating counterfeit medicines in Vietnam. Issues Definitions of counterfeit medicines and concerned legal documents National coordination Number of.
Country Presentation Myanmar
Combating Counterfeit Drugs in China Chen Xu Ph.D. Director of Division of Drug Supervision and Inspection Department of Drug Market.
Anti- Piracy Unit (APU) REPUBLIC OF MAURITIUS 1. MAURITIUS 2.
International Medical Products Anti-CounterfeitingTaskforce.
First ASEAN-China Conference on Combating Counterfeit Medical Products Jakarta November 2007 CHOO CHEOK HANG DEPARTMENT OF PHARMACEUTICAL SERVICES.
Republic of Moldova Nuclear and Radiological Safety Regulatory Infrastructure in Republic of Moldova Ionel Bălan, National Agency for Regulation of Nuclear.
0 - 0.
Addition Facts
Welcome to Who Wants to be a Millionaire
Welcome to Who Wants to be a Millionaire
GHS Implementation in Vietnam
Break Time Remaining 10:00.
This module: Telling the time
KARACHI FASHION WEEK CHAPTER 3 JANUARY 27 – 30, 2011 FASHION RUNWAY SHOW FASHION RUNWAY SHOW BRAND PRESENTATIONS BRAND PRESENTATIONS FASHION BRANDS EXHIBITIONS.
Benefits of competition for low-income groups Andrey Tsyganov, Deputy Head of the FAS Russia FEDERAL ANTIMONOPOLY SERVICE Sofia Competition Forum November.
1 The European Union. 2 Some basic information The EU currently includes 27 states It has 23 official languages The EU has a population of over 500 million.
Influenza Vaccine Manufacturing
EU Market Situation for Eggs and Poultry Management Committee 21 June 2012.
Business Promotion Opportunities Logos Mahatma Mandir, Sector-13, Gandhinagar, Nr Ahmedabad.
15. Oktober Oktober Oktober 2012.
2014 National Patient Safety Goals
Promoting patient-centred healthcare around the world Advancing the fight against counterfeit medicines Ms. Regina Kamoga IAPO Board Member, Country Manager,
We are learning how to read the 24 hour clock
AN OVERVIEW OF HEALTH RESEARCH ETHICS IN INDONESIA By : SURIADI GUNAWAN.
Produced by the Department of Learning and Teaching Resources, Belfast Institute. Want to be a xxxxx? Welcome to College Name Click here to start.
Want to be a xxxxx? Welcome to College Name Click here to start.
1 First EMRAS II Technical Meeting IAEA Headquarters, Vienna, 19–23 January 2009.
Addition 1’s to 20.
Test B, 100 Subtraction Facts
: 3 00.
5 minutes.
Week 1.
Visions of Australia – Regional Exhibition Touring Fund Applicant organisation Exhibition title Exhibition Sample Support Material Instructions 1) Please.
Clock will move after 1 minute
Highlights From the Survey on the Use of Funds Under Title II, Part A
Select a time to count down from the clock above
Murach’s OS/390 and z/OS JCLChapter 16, Slide 1 © 2002, Mike Murach & Associates, Inc.
MALAWI GOVERNMENT MINISTRY OF HEALTH PROGRESS ON GOOD GOVERNANCE IN THE PHARMACEUTICAL SECTOR IN MALAWI By Dr Charles Mwansambo Secretary for Health 20.
Zambia’s Porous Borders & the Influx of Medicines.
Experience on quality of anti-malarials in Lao PDR by Dr.Somthavy CHANGVISOMMID Deputy Director of Food and Drug Department Ministry of Health, Lao PDR.
Country Report By : Fueyching KHOUNSILIVANH. Agenda  Country Profile  Champasak Technical-Vocational College 2.
Presentation transcript:

Counterfeit and Substandard medicine in Laos Report country

General situation Areas –Area: 236,800 sq. km. –Capital: Vientiane Border –China, Burma, Vietnam, Thailand, Cambodia Population –6.5 million Provinces –17 provinces

Legislative infrastructures (1) The legislation is used to against counterfeit medical products: –Drug Law: Regulation: –Drug registration, –Drug import-Export –Drug selling : hologram, using of bill –Civil Law: Article 133: Produce, sell bad quality drug (3 months to 3 years for sanction).

Legislative infrastructures (2) National definition of counterfeit medical product: –In drug law, at article 11 defined a counterfeit drug as: Counterfeit drug is a traditional or modern drug was mimicked, copied from genuine drug which was registered. –Definition from WHO was also used

A 250 mg B 250 mg A 250 mg B 250 mg fake A 250 mg B 250 mg A 250 mg C 250 mg fake A 250 mg B 250 mg C 250 mg fake A 250 mg B 250 mg A 250 mg B 250 mg genuine

A 250 mg B 250 mg A 200 mg B 120 mg fake A 250 mg C 250 mg fake C 250 mg fake A 250 mg B 250 mg A 250 mg B 250 mg genuine A 250 mg B 250 mg A 250 mg B 250 mg

A 200 mg B 120 mg fake Sub standard genuine A 250 mg B 250 mg A 250 mg B 250 mg 球 A 250 mg B 250 mg A 250 mg B 250 mg A 200 mg B 120 mg A 250 mg B 250 mg A 250 mg B 250 mg

Legislative infrastructures (3) The gaps in current legislation Implementation, following to law and regulations were still not strictly, activities to fill the gaps : Registration and surveillance Reliable enforcement Punishment by capital law Information campaigns

Supported organizations: WHO USPDQI Welcome Trust Global fund SIDA (KTS) Coordination among government institutions National Coordination (1)

Drug regulator in Laos Importation Market Relevant org. Post marketing inspection

Problems/Limitations of coordination: –Lack of team work Effect of coordination: –Need more improve National Coordination (2)

¦½-²¾®-µ¾-¯º´--µøÈ-¦-¯-¯-쾸

Previously reporting on counterfeit OrganizationSamplesSub-StandardFake SIDA+Gov (17%)7 (0.9%) EU(anti-malaria)17055(32%)10(6%) USPDQ(anti-malaria)21520(9.3%)18(8.4%) JICWELS481

14 I.Counterfeit Medicines 1. Artersunate 50mg, Tablet, Lot No.: , Exp.: 06/2009, China 2. Artersunate 50mg, Tablet, Lot No.: 50232, Exp.: 02/2009, China 3. Artersunate 50mg, Tablet, Lot No.: , Exp.: 02/2009, China II. Sub-Standard Medicines 1. Metronidazole 250mg, Tablet, Lot No.: 00206, Exp 10/2010, Manufacturer : Pharmaceutical Factory No. 2 Laos 2. Erythromycine 250mg, Tablet, Lot No.: ,Exp 03/2010, Manufacturer: CBF Pharmaceutical Factory Laos

15 Action Taken 1. Saravan Province: - 05/07/2007: Received report from FDQCC - 06/07/2007: Informed Saravan Provincial Health Office for Investigating and taking action Thavysab Pharmacy Owner & Conduct an inspection of other pharmacies in the whole province. - 06/07/2007: Informed all Provincial Health Offices in the whole country to conduct an Inspection of counterfeit Artesunate Lot No , 2 weeks later, receiving reports from Six Provinces, not founded any counterfeits. 08/07/2007: Informed Saravan Provincial Health Office again to conduct investigation and taking action of Thavysab Pharmacy as follow by FDD Form

16 Action Taken 1. Khammouane Province: - 12/09/2007: Received report of analysis from FDQCC - 12/09/2007: Informed Khammouane P H O for Investigating and taking action to Anoulak Pharmacy Owner and Conduct an inspection of other pharmacies in the whole province. - 09/10/2007: Receiving report from Khammouane P H O. -Founded more counterfeits at pharmacies, Khammouane Drug Import Export Company, Sebangfai Dist. Hospital and Prov. Hospital, - Total amount: 44 blisters, Conducted investigation, knowing source of counterfeit came from private Vietnamese, pharmacy and company - Confiscated all amount of Counterfeits.

17 Action Taken -Luang Namtha Province: - 01/10/2007: Receiving report of analysis from FDQCC - 08/10/2007: Informed Luangnamtha P H O to conduct an inspection of Military Hospital of Luangnamtha province, other pharmacies and making Investigation. FDD did not receive report yet until now.

18 Action taken 1.Attopeu Province: - 23/07/2007: Receiving from Dr. Paul Newton - 26/07/2007: Informed Attopeu P H O to conduct an Inspection of Hospitals and Pharmacies - 15/08/2007: Receiving report from Province Not founded any Counterfeits.

Thank